Journal Article

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF

Tóth, Nóra Melinda, Polivka, Lőrinc, Horváth, Péter, Eszes, Noémi, Nagy, Tamás, Müller, Veronika, Bohács, Anikó

2023

Overview

Diagnosing interstitial lung disease (ILD) can be a challenging process. New biomarkers may support diagnostic decisions. Elevated serum progranulin (PGRN) levels have been reported in liver fibrosis and dermatomyositis-associated acute interstitial pneumonia. Our aim was to assess the role of PGRN in the differential diagnosis of idiopathic pulmonary fibrosis (IPF) and other ILDs. Serum levels of PGRN were measured by enzyme-linked immunosorbent assay in stable IPF (n = 40), non-IPF ILD (n = 48) and healthy controls (n = 17). Patient characteristics, lung function, CO diffusion (DLCO), arterial blood gases, 6-min walk test, laboratory parameters and high-resolution (HR)CT pattern were assessed. In stable IPF, PGRN levels did not differ from healthy controls; however, serum PGRN levels were significantly higher in non-IPF ILD patients compared to healthy subjects and IPF (53.47 ± 15.38 vs. 40.99 ± 5.33 vs. 44.66 ± 7.77 ng/mL respectively; p < 0.01). The HRCT pattern of usual interstitial pneumonia (UIP) was associated with normal PGRN level, while for non-UIP patterns, significantly elevated PGRN level was measured. Elevated serum PGRN levels may be associated with non-IPF ILD, especially non-UIP patterns and might be helpful in cases of unclear radiological patterns in the differentiation between IPF and other ILDs.

• Publisher: MDPI AG,MDPI
• Subject: Bacterial pneumonia / Biomarkers / Cell growth / Clinical medicine / Diagnosis / Enzyme-linked immunosorbent assay / Enzymes / Growth factors / Laboratories / Lung diseases / Patients / Pneumonia / Serology / Tissue engineering / Wound healing